These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15065532

  • 21. Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
    Kato S, Ozawa K, Sekine H, Ohyauchi M, Shimosegawa T, Minoura T, Iinuma K.
    J Gastroenterol; 2005 Jan; 40(1):94-7. PubMed ID: 15692795
    [Abstract] [Full Text] [Related]

  • 22. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S, Teyssen S, Kölbel CB, Singer MV.
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [Abstract] [Full Text] [Related]

  • 23. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A.
    Med Clin (Barc); 1998 Jan 17; 110(1):1-5. PubMed ID: 9527978
    [Abstract] [Full Text] [Related]

  • 24. [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
    Inoue K, Sugano K.
    Nihon Rinsho; 2002 Feb 17; 60 Suppl 2():460-4. PubMed ID: 11979828
    [No Abstract] [Full Text] [Related]

  • 25. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA.
    Eksp Klin Gastroenterol; 2004 Feb 17; (3):40-4. PubMed ID: 15560400
    [No Abstract] [Full Text] [Related]

  • 26. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Feb 17; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 27. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.
    Schweiz Med Wochenschr; 1997 Apr 26; 127(17):722-7. PubMed ID: 9221483
    [Abstract] [Full Text] [Related]

  • 28. [Dual therapy for Helicobacter pylori resistance to anti microbial agents].
    Fu HY, Kawano S, Tanimura H.
    Nihon Rinsho; 2002 Feb 26; 60 Suppl 2():423-6. PubMed ID: 11979819
    [No Abstract] [Full Text] [Related]

  • 29. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 30. [H. pylori eradication package set (Lansap)].
    Kawai T, Kawakami K, Moriyasu F, Takagi Y.
    Nihon Rinsho; 2005 Nov 15; 63 Suppl 11():361-5. PubMed ID: 16363560
    [No Abstract] [Full Text] [Related]

  • 31. [Pariet in current patterns of eradication of Helicobacter pylori infection].
    Baranskaia EK.
    Voen Med Zh; 2001 Apr 15; 322(4):54-8. PubMed ID: 11547668
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 15; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
    Iwasaki A.
    Nihon Rinsho; 1999 Jan 15; 57(1):127-33. PubMed ID: 10036949
    [Abstract] [Full Text] [Related]

  • 35. [Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
    Sugano K.
    Nihon Naika Gakkai Zasshi; 2002 Mar 20; 91 Suppl():32-7. PubMed ID: 11989260
    [No Abstract] [Full Text] [Related]

  • 36. [Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
    Tokunaga K, Takahashi S.
    Nihon Rinsho; 2002 Feb 20; 60 Suppl 2():445-8. PubMed ID: 11979824
    [No Abstract] [Full Text] [Related]

  • 37. [Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
    Gisbert JP, Boixeda D, Martín de Argila C, García Plaza A.
    Rev Clin Esp; 1998 Oct 20; 198(10):678-83. PubMed ID: 9844458
    [No Abstract] [Full Text] [Related]

  • 38. Which proton pump inhibitor should we use?
    Williams CN.
    Can J Gastroenterol; 1997 Oct 20; 11(1):29. PubMed ID: 9113794
    [No Abstract] [Full Text] [Related]

  • 39. [Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor].
    Gościmski A, Matras J, Wallner G.
    Wiad Lek; 2002 Oct 20; 55(1-2):19-28. PubMed ID: 12043311
    [Abstract] [Full Text] [Related]

  • 40. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N.
    Am J Gastroenterol; 2005 Nov 20; 100(11):2393-4. PubMed ID: 16279890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.